Harmony is trusted.

Clinicians worldwide have screened over 1 million pregnancies with Harmony. It’s the only NIPT validated in the general pregnancy population, demonstrating exceptional detection rate and false-positive rate.1 Women can be tested in as early as ten weeks gestation, and your results are sent to your healthcare provider.

Learn More About Taking the Test


Answers that matter.

In the New England Journal of Medicine’s NEXT (Non-Invasive Examination of Trisomy) Study — the largest study of its kind —the Harmony Non-Invasive Prenatal Test was compared to First Trimester Combined Screening (FTS**) tests and was found to be have significantly better detection rate and false-positive rate. The Harmony test gives you the confidence you want in your results.1

With Harmony’s greater accuracy, chances for further invasive testing procedures, such as amniocentesis, may be reduced.

Learn More About Finding Clarity


References: 1. Norton et al. N Engl J Med. 2015 Apr 23;372(17):1589-97. 2. Norton et al. Am J Obstet Gynecol. 2012 Aug;207(2):137.e1-8. 3. Verweij et al. Prenat Diagn. 2013 Oct;33(10):996-1001. 4. Nicolaides et al. Am J Obstet Gynecol. 2012 Nov;207(5):374.e1-6. 5. Gil et al. Fetal Diagn Ther. 2014;35:204-11.

The Harmony Prenatal Test measures a woman’s risk of carrying a baby with chromosomal conditions such as trisomies 21, 18 and 13. If your test indicates a high probability result, talk with your healthcare provider about what further diagnostic testing is needed to confirm the result. The Harmony Prenatal Test was developed by Ariosa Diagnostics, a laboratory certified by the federal government to perform highly complex tests. This test is a lab–developed test and has not been reviewed or approved by the FDA.